Fluconazole Exposure in Plasma and Bile During Continuous Venovenous Hemodialysis
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
Therapeutic drug monitoring - 41(2019), 4 vom: 01. Aug., Seite 544-546 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Oualha, Mehdi [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 10.03.2020 Date Revised 10.03.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.1097/FTD.0000000000000641 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM298736691 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM298736691 | ||
003 | DE-627 | ||
005 | 20231225094813.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/FTD.0000000000000641 |2 doi | |
028 | 5 | 2 | |a pubmed24n0995.xml |
035 | |a (DE-627)NLM298736691 | ||
035 | |a (NLM)31259879 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Oualha, Mehdi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fluconazole Exposure in Plasma and Bile During Continuous Venovenous Hemodialysis |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.03.2020 | ||
500 | |a Date Revised 10.03.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 7 | |a Fluconazole |2 NLM | |
650 | 7 | |a 8VZV102JFY |2 NLM | |
700 | 1 | |a Tréluyer, Jean-Marc |e verfasserin |4 aut | |
700 | 1 | |a Moshous, Despina |e verfasserin |4 aut | |
700 | 1 | |a Bougnoux, Marie-Elisabeth |e verfasserin |4 aut | |
700 | 1 | |a Starck, Julie |e verfasserin |4 aut | |
700 | 1 | |a Renolleau, Sylvain |e verfasserin |4 aut | |
700 | 1 | |a Gana, Inès |e verfasserin |4 aut | |
700 | 1 | |a Benaboud, Sihem |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Therapeutic drug monitoring |d 1993 |g 41(2019), 4 vom: 01. Aug., Seite 544-546 |w (DE-627)NLM000962295 |x 1536-3694 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2019 |g number:4 |g day:01 |g month:08 |g pages:544-546 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/FTD.0000000000000641 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 41 |j 2019 |e 4 |b 01 |c 08 |h 544-546 |